North America Automated And Closed Cell Therapy Processing Systems Market Size & Outlook

The automated and closed cell therapy processing systems market in North America is expected to reach a projected revenue of US$ 2,030.4 million by 2030. A compound annual growth rate of 19.4% is expected of North America automated and closed cell therapy processing systems market from 2025 to 2030.
Revenue, 2024 (US$M)
$706.2
Forecast, 2030 (US$M)
$2,030.4
CAGR, 2025 - 2030
19.4%
Report Coverage
North America

North America automated and closed cell therapy processing systems market, 2018-2030 (US$M)

North

Related Markets

North America automated and closed cell therapy processing systems market highlights

  • The North America automated and closed cell therapy processing systems market generated a revenue of USD 706.1 million in 2024.
  • The market is expected to grow at a CAGR of 19.4% from 2025 to 2030.
  • In terms of segment, pre-commercial/ r&d scale was the largest revenue generating scale in 2024.
  • Commercial Scale is the most lucrative scale segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.

North America data book summary

Market revenue in 2024USD 706.1 million
Market revenue in 2030USD 2,030.5 million
Growth rate19.4% (CAGR from 2025 to 2030)
Largest segmentPre-commercial/ r&d scale
Fastest growing segmentCommercial Scale
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPre-commercial/ R&D Scale, Commercial Scale
Key market players worldwideMiltenyi Biotec, Lonza Group Ltd, Fresenius SE & Co KGaA, Cytiva, Terumo Corp, Sartorius AG, ThermoGenesis Holdings Inc, Thermo Fisher Scientific Inc, Biospherix, Cellares

Other key industry trends

  • In terms of revenue, North America region accounted for 50.1% of the global automated and closed cell therapy processing systems market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 888.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Automated and Closed Cell Therapy Processing Systems Market Companies

Name Profile # Employees HQ Website

North America automated and closed cell therapy processing systems market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to automated and closed cell therapy processing systems market will help companies and investors design strategic landscapes.


Pre-commercial/ r&d scale was the largest segment with a revenue share of 88.77% in 2024. Horizon Databook has segmented the North America automated and closed cell therapy processing systems market based on pre-commercial/ r&d scale, commercial scale covering the revenue growth of each sub-segment from 2018 to 2030.


North America is anticipated to witness significant market growth in the automated and closed cell therapy processing systems market due to rising involvement of companies in R&D of cell therapies. The market growth of this region can be attributed to presence of a large number of institutes and centers involved in manufacturing cell therapy.

Moreover, robust government support, presence of key operating players, and strategic initiatives for market expansion are further fueling the market growth. For instance, in June 2020, ThermoGenesis Holdings, Inc. and Corning Incorporated’s Life Sciences Division entered into a global distribution agreement for its X-SERIES products.

In August 2021, Artiva Biopharmaceuticals announced the expansion in the U.S. with a new R&D and manufacturing facility for cell therapies.

Reasons to subscribe to North America automated and closed cell therapy processing systems market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America automated and closed cell therapy processing systems market databook

  • Our clientele includes a mix of automated and closed cell therapy processing systems market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America automated and closed cell therapy processing systems market , including forecasts for subscribers. This continent databook contains high-level insights into North America automated and closed cell therapy processing systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America automated closed cell therapy processing systems market report size, by country, 2018-2030 (US$M)

North America Automated and Closed Cell Therapy Processing Systems Market Outlook Share, 2024 & 2030 (US$M)

North America automated closed cell therapy processing systems market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more